Organon & Co | OGN - 当期純利益

株価
13.34
毎日の変更
0.02 0.15%
毎月
134.04%
毎年
2.77%
Q2 予測
11.02




当期純利益 変化する 日付
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Celltrion KRW 331.35B 270.18B 2025-09
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Glaxosmithkline GBP 846.06M 1.87B 2025-12
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Merck USD 2.96B 2.82B 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Organon & Co USD 160M 15M 2025-09
Ovoca Bio EUR -765K 4.89M 2025-06
Pharma Mar EUR 59.66M 63.76M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12